Basic Information
RNALocate ID: | RLID:11001495 |
RNA Symbol: | hsa-miR-212-3p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-212 |
RNA ID: | miRBase:MIMAT0000269 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 19627513 |
Tissue/Cell Line: | Saliva |
Method: | miRNA microarray|Quantitative qPCR |
Description: | Exosomal miRNAs as potential biomarkers and therapeutic targets. Data are collected from Table 1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001654 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001655 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001656 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:11001494 | Exosome | Plasma | 19289371 |
RLID:11001496 | Exosome | Brain tissue | 23382797 |
RLID:11001497 | Exosome | Plasma | 23663360 |
RLID:11001498 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11001499 | Microvesicle | Follicular fluid | 23666971 |
RLID:11001500 | Microvesicle | Cerebrospinal fluid | 24797360 |
RLID-D:11000330 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
RLID-D:11001170 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-212-3p | Oral squamous cell carcinoma | MNDR-E-MI-28795 |
MNDR | hsa-miR-212-3p | Medulloblastoma | MNDR-E-MI-28796 |
MNDR | hsa-miR-212-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-28797 |
MNDR | hsa-miR-212-3p | Ovarian clear cell carcinoma | MNDR-E-MI-28798 |
MNDR | hsa-miR-212-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-28799 |
MNDR | hsa-miR-212-3p | Lymphoma | MNDR-E-MI-28800 |
MNDR | hsa-miR-212-3p | Non-hodgkin lymphoma | MNDR-E-MI-28801 |
MNDR | hsa-miR-212-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-28802 |
MNDR | hsa-miR-212-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-28803 |
MNDR | hsa-miR-212-3p | Her2-receptor positive breast cancer | MNDR-E-MI-28804 |
MNDR | hsa-miR-212-3p | Anencephaly | MNDR-E-MI-28805 |
MNDR | hsa-miR-212-3p | Familial temporal lobe epilepsy 3 | MNDR-E-MI-28806 |
MNDR | hsa-miR-212-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-28807 |
MNDR | hsa-miR-212-3p | Chronic lymphocytic leukemia | MNDR-E-MI-28808 |
MNDR | hsa-miR-212-3p | Gastric cancer | MNDR-E-MI-28809 |
MNDR | hsa-miR-212-3p | Alzheimer disease | MNDR-E-MI-28810 |
MNDR | hsa-miR-212-3p | Dysautonomia familial | MNDR-E-MI-28811 |
MNDR | hsa-miR-212-3p | Lewy body dementia | MNDR-E-MI-28812 |
MNDR | hsa-miR-212-3p | Primary biliary cirrhosis | MNDR-E-MI-28813 |
MNDR | hsa-miR-212-3p | Friedreich ataxia | MNDR-E-MI-28814 |
MNDR | hsa-miR-212-3p | Huntington disease | MNDR-E-MI-28815 |
MNDR | hsa-miR-212-3p | Chorea | MNDR-E-MI-28816 |
MNDR | hsa-miR-212-3p | Cardiovascular disease | MNDR-E-MI-28817 |
MNDR | hsa-miR-212-3p | Uterine fibroid | MNDR-E-MI-28818 |
MNDR | hsa-miR-212-3p | Lung cancer | MNDR-E-MI-28819 |
MNDR | hsa-miR-212-3p | Fragile x syndrome | MNDR-E-MI-28820 |
MNDR | hsa-miR-212-3p | Parkinson disease | MNDR-E-MI-28821 |
MNDR | hsa-miR-212-3p | Breast cancer | MNDR-E-MI-28822 |
MNDR | hsa-miR-212-3p | Pituitary neoplasms | MNDR-E-MI-28823 |
MNDR | hsa-miR-212-3p | Pancreatic cancer | MNDR-E-MI-28824 |
MNDR | hsa-miR-212-3p | Melanoma | MNDR-E-MI-28825 |
MNDR | hsa-miR-212-3p | Nephroblastoma | MNDR-E-MI-28826 |
MNDR | hsa-miR-212-3p | Colon cancer | MNDR-E-MI-28827 |
MNDR | hsa-miR-212-3p | Ischemic attack transient | MNDR-E-MI-28828 |
MNDR | hsa-miR-212-3p | Colon adenocarcinoma | MNDR-E-MI-28829 |
MNDR | hsa-miR-212-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-28830 |
MNDR | hsa-miR-212-3p | Prostate adenocarcinoma | MNDR-E-MI-28831 |
MNDR | hsa-miR-212-3p | Glioblastoma | MNDR-E-MI-28832 |
MNDR | hsa-miR-212-3p | Glioma | MNDR-E-MI-28833 |
MNDR | hsa-miR-212-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-28834 |
MNDR | hsa-miR-212-3p | Temporal lobe epilepsy | MNDR-E-MI-28835 |
MNDR | hsa-miR-212-3p | Osteosarcoma | MNDR-E-MI-28836 |
MNDR | hsa-miR-212-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-28837 |
MNDR | hsa-miR-212-3p | Uterine cancer | MNDR-E-MI-28838 |
MNDR | hsa-miR-212-3p | Pituitary adenoma | MNDR-E-MI-28839 |
MNDR | hsa-miR-212-3p | Lung squamous cell carcinoma | MNDR-E-MI-28840 |
MNDR | hsa-miR-212-3p | Non-small cell lung cancer | MNDR-E-MI-28841 |
MNDR | hsa-miR-212-3p | Lung adenocarcinoma | MNDR-E-MI-28842 |
MNDR | hsa-miR-212-3p | Thyroid carcinoma | MNDR-E-MI-28843 |
MNDR | hsa-miR-212-3p | Ovarian carcinoma | MNDR-E-MI-28844 |
MNDR | hsa-miR-212-3p | Bladder urothelial carcinoma | MNDR-E-MI-28845 |
MNDR | hsa-miR-212-3p | Pancreatic adenocarcinoma | MNDR-E-MI-28846 |
MNDR | hsa-miR-212-3p | Carcinoma renal cell | MNDR-E-MI-28847 |
MNDR | hsa-miR-212-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-28848 |
MNDR | hsa-miR-212-3p | Clear cell renal cell carcinoma | MNDR-E-MI-28849 |
MNDR | hsa-miR-212-3p | Cholangiocarcinoma | MNDR-E-MI-28850 |
MNDR | hsa-miR-212-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-28851 |
MNDR | hsa-miR-212-3p | Hepatocellular carcinoma | MNDR-E-MI-28852 |
MNDR | hsa-miR-212-3p | B-cell lymphoma | MNDR-E-MI-28853 |
MNDR | hsa-miR-212-3p | Malignant pleural mesothelioma | MNDR-E-MI-28854 |
MNDR | hsa-miR-212-3p | Chronic myeloid leukemia | MNDR-E-MI-28855 |
MNDR | hsa-miR-212-3p | Burkitt lymphoma | MNDR-E-MI-28856 |
MNDR | hsa-miR-212-3p | Tonsil cancer | MNDR-E-MI-28857 |
MNDR | hsa-miR-212-3p | Skin cutaneous melanoma | MNDR-E-MI-28858 |
MNDR | hsa-miR-212-3p | Skin melanoma | MNDR-E-MI-28859 |
MNDR | hsa-miR-212-3p | Frontotemporal dementia | MNDR-E-MI-28860 |
MNDR | hsa-miR-212-3p | Colorectal cancer | MNDR-E-MI-28861 |
MNDR | hsa-miR-212-3p | Nasopharynx carcinoma | MNDR-E-MI-28862 |
MNDR | hsa-miR-212-3p | Acute lymphocytic leukemia | MNDR-E-MI-28863 |
MNDR | hsa-miR-212-3p | Nasopharyngeal cancer | MNDR-E-MI-28864 |
MNDR | hsa-miR-212-3p | Gait ataxia | MNDR-E-MI-28865 |
MNDR | hsa-miR-212-3p | Breast cancer her3+ negative | MNDR-E-MI-28866 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG2 | Homo sapiens | RR00024742 |
TOP